These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 23689938)

  • 1. Thiol-ene click chemistry for the synthesis of highly effective glycosyl sulfonamide carbonic anhydrase inhibitors.
    Saada MC; Ombouma J; Montero JL; Supuran CT; Winum JY
    Chem Commun (Camb); 2013 Jun; 49(50):5699-701. PubMed ID: 23689938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbonic anhydrase inhibitors: Selective inhibition of the extracellular, tumor-associated isoforms IX and XII over isozymes I and II with glycosyl-thioureido-sulfonamides.
    Smaine FZ; Winum JY; Montero JL; Regainia Z; Vullo D; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2007 Sep; 17(18):5096-100. PubMed ID: 17646100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulfonamides incorporating 1,3,5-triazine moieties selectively and potently inhibit carbonic anhydrase transmembrane isoforms IX, XII and XIV over cytosolic isoforms I and II: Solution and X-ray crystallographic studies.
    Carta F; Garaj V; Maresca A; Wagner J; Avvaru BS; Robbins AH; Scozzafava A; McKenna R; Supuran CT
    Bioorg Med Chem; 2011 May; 19(10):3105-19. PubMed ID: 21515057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbonic anhydrase inhibitors: copper(II) complexes of polyamino-polycarboxylamido aromatic/heterocyclic sulfonamides are very potent inhibitors of the tumor-associated isoforms IX and XII.
    Rami M; Winum JY; Innocenti A; Montero JL; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2008 Jan; 18(2):836-41. PubMed ID: 18042384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbonic anhydrase inhibitors. Interaction of 2-(hydrazinocarbonyl)-3-phenyl-1H-indole-5-sulfonamide with 12 mammalian isoforms: kinetic and X-ray crystallographic studies.
    Güzel O; Temperini C; Innocenti A; Scozzafava A; Salman A; Supuran CT
    Bioorg Med Chem Lett; 2008 Jan; 18(1):152-8. PubMed ID: 18024029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A class of sulfonamide carbonic anhydrase inhibitors with neuropathic pain modulating effects.
    Carta F; Di Cesare Mannelli L; Pinard M; Ghelardini C; Scozzafava A; McKenna R; Supuran CT
    Bioorg Med Chem; 2015 Apr; 23(8):1828-40. PubMed ID: 25766630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of carbonic anhydrase isoforms I, II, IV, VII and XII with carboxylates and sulfonamides incorporating phthalimide/phthalic anhydride scaffolds.
    El-Azab AS; Abdel-Aziz AA; Ayyad RR; Ceruso M; Supuran CT
    Bioorg Med Chem; 2016 Jan; 24(1):20-5. PubMed ID: 26678172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbonic anhydrase inhibitors. Phenacetyl-, pyridylacetyl- and thienylacetyl-substituted aromatic sulfonamides act as potent and selective isoform VII inhibitors.
    Güzel O; Innocenti A; Scozzafava A; Salman A; Supuran CT
    Bioorg Med Chem Lett; 2009 Jun; 19(12):3170-3. PubMed ID: 19435663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbonic anhydrase inhibitors: inhibition of human cytosolic isozymes I and II and tumor-associated isozymes IX and XII with S-substituted 4-chloro-2-mercapto-5-methyl-benzenesulfonamides.
    Saczewski F; Innocenti A; Sławiński J; Kornicka A; Brzozowski Z; Pomarnacka E; Scozzafava A; Temperini C; Supuran CT
    Bioorg Med Chem; 2008 Apr; 16(7):3933-40. PubMed ID: 18242998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbonic anhydrase inhibitors: inhibition of the tumor-associated isozyme IX with fluorine-containing sulfonamides. The first subnanomolar CA IX inhibitor discovered.
    Vullo D; Scozzafava A; Pastorekova S; Pastorek J; Supuran CT
    Bioorg Med Chem Lett; 2004 May; 14(9):2351-6. PubMed ID: 15081039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbonic anhydrase inhibitors. Benzenesulfonamides incorporating cyanoacrylamide moieties strongly inhibit Saccharomyces cerevisiae β-carbonic anhydrase.
    Alafeefy AM; Isik S; Al-Jaber NA; Vullo D; Abdel-Aziz HA; Ashour AE; Awaad AS; Capasso C; Supuran CT
    Bioorg Med Chem Lett; 2013 Jun; 23(12):3570-5. PubMed ID: 23642478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbonic anhydrase inhibitors. Aromatic/heterocyclic sulfonamides incorporating phenacetyl, pyridylacetyl and thienylacetyl tails act as potent inhibitors of human mitochondrial isoforms VA and VB.
    Güzel O; Innocenti A; Scozzafava A; Salman A; Supuran CT
    Bioorg Med Chem; 2009 Jul; 17(14):4894-9. PubMed ID: 19539481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of potent carbonic anhydrase inhibitors incorporating both sulfonamide and sulfamide groups.
    D'Ambrosio K; Smaine FZ; Carta F; De Simone G; Winum JY; Supuran CT
    J Med Chem; 2012 Aug; 55(15):6776-83. PubMed ID: 22775345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbonic anhydrase inhibitors. Diazenylbenzenesulfonamides are potent and selective inhibitors of the tumor-associated isozymes IX and XII over the cytosolic isoforms I and II.
    Carta F; Maresca A; Scozzafava A; Vullo D; Supuran CT
    Bioorg Med Chem; 2009 Oct; 17(20):7093-9. PubMed ID: 19773173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New chemotypes acting as isozyme-selective carbonic anhydrase inhibitors with low affinity for the offtarget cytosolic isoform II.
    Carta F; Vullo D; Maresca A; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2012 Mar; 22(6):2182-5. PubMed ID: 22365761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromone containing sulfonamides as potent carbonic anhydrase inhibitors.
    Ekinci D; Al-Rashida M; Abbas G; Şentürk M; Supuran CT
    J Enzyme Inhib Med Chem; 2012 Oct; 27(5):744-7. PubMed ID: 21985426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbonic anhydrase inhibitors. Regioselective synthesis of novel series 1-substituted 1,4-dihydro-4-oxo-3-pyridinesulfonamides and their inhibition of the human cytosolic isozymes I and II and transmembrane cancer-associated isozymes IX and XII.
    Brzozowski Z; Sławiński J; Vullo D; Supuran CT
    Eur J Med Chem; 2012 Oct; 56():282-91. PubMed ID: 22910138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S-glycosyl primary sulfonamides--a new structural class for selective inhibition of cancer-associated carbonic anhydrases.
    Lopez M; Paul B; Hofmann A; Morizzi J; Wu QK; Charman SA; Innocenti A; Vullo D; Supuran CT; Poulsen SA
    J Med Chem; 2009 Oct; 52(20):6421-32. PubMed ID: 19827837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbonic anhydrase inhibitors. Sulfonamide diuretics revisited--old leads for new applications?
    Temperini C; Cecchi A; Scozzafava A; Supuran CT
    Org Biomol Chem; 2008 Jul; 6(14):2499-506. PubMed ID: 18600270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbonic anhydrase inhibitors. Inhibition of cytosolic isoforms I and II, and extracellular isoforms IV, IX, and XII with sulfamides incorporating sugar moieties.
    Colinas PA; Bravo RD; Vullo D; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2007 Sep; 17(18):5086-90. PubMed ID: 17658252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.